Conorfamide-As1a is a conopeptide-related neuropeptide containing aromatic and amidated residues suited for receptor-modulation studies. Its sequence supports compact folding and selective binding to neuronal targets in vitro. Researchers investigate structure-activity relationships using electrophysiology and spectroscopy. Applications include neurochemical signaling research, peptide-toxin motif analysis, and receptor-epitope mapping.
CAT No: R2740
Conorfamide-As1a is a unique peptide derived from the venom of marine cone snails, belonging to the conorfamide family known for their distinctive structural motifs and rich pharmacological diversity. Featuring an amidated C-terminus and a sequence that enables selective receptor interactions, Conorfamide-As1a has attracted considerable attention from the scientific community for its ability to modulate neuronal signaling pathways. Researchers are particularly interested in its potential to interact with specific ion channels and G protein-coupled receptors, making it a valuable molecular tool for neuroscience and molecular pharmacology investigations. Its synthesis and isolation have enabled a deeper understanding of conotoxin diversity, providing a foundation for exploring novel mechanisms of action within neurobiology. The peptide's stability and bioactivity in experimental settings further enhance its suitability for a wide range of laboratory and research applications.
Neuropharmacology research: As a member of the conorfamide family, Conorfamide-As1a is frequently utilized in neuropharmacology to investigate the modulation of neuronal excitability and synaptic transmission. By interacting with neuronal receptors and ion channels, it enables researchers to dissect the signaling pathways underlying neurotransmitter release and neuronal communication. The peptide's selective activity provides insights into the physiological roles of specific receptor subtypes and aids in the identification of novel targets for neurological research. Its application in electrophysiological assays and receptor binding studies helps elucidate the molecular mechanisms governing synaptic plasticity and neuronal response to external stimuli.
Ion channel studies: In the field of ion channel research, Conorfamide-As1a serves as a powerful probe for characterizing the functional properties of voltage-gated and ligand-gated ion channels. Its ability to modulate channel activity allows scientists to map channel subunit composition, gating mechanisms, and pharmacological profiles. The use of this peptide in patch-clamp experiments and high-throughput screening platforms facilitates the discovery of new modulators and enhances the understanding of ion channelopathies. By providing a means to selectively influence ion channel behavior, Conorfamide-As1a contributes to the advancement of ion channel-targeted research.
GPCR signaling analysis: Owing to its structural similarity with endogenous neuropeptides, Conorfamide-As1a is also employed in the analysis of G protein-coupled receptor (GPCR) signaling pathways. Researchers leverage its receptor selectivity to study GPCR activation, desensitization, and downstream signaling cascades in various model systems. The peptide's use in ligand-binding assays and cellular signaling experiments supports the identification of receptor subtypes and the mapping of intracellular pathways involved in neuromodulation. Such studies are instrumental in expanding the knowledge of GPCR function and their roles in complex physiological processes.
Venom peptide evolution: The study of Conorfamide-As1a extends into the evolutionary biology of venom peptides, where it serves as a model for understanding the diversification of conotoxins among marine gastropods. Comparative sequence analysis and functional assays involving this peptide help elucidate the evolutionary pressures and genetic mechanisms that give rise to the structural and functional diversity observed in cone snail venoms. These investigations not only shed light on the adaptive significance of venom peptides but also inform the discovery of novel bioactive molecules with unique pharmacological properties.
Peptide engineering and design: In the realm of peptide engineering, Conorfamide-As1a provides a template for the rational design of synthetic analogs with tailored biological activities. Its well-defined structure and receptor interactions guide the development of modified peptides for use in receptor mapping, structure-activity relationship studies, and the creation of molecular tools for neurobiological research. By serving as a scaffold for the generation of novel peptides, it accelerates the innovation of research reagents and supports the advancement of peptide-based technologies in life sciences.
2. Myotropic activity of allatostatins in tenebrionid beetles
5. Low bone turnover and low BMD in Down syndrome: effect of intermittent PTH treatment
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More